pharma
FDA greenlights Nebriva’s Xenleta for community-acquired bacterial pneumonia
August 20, 2019Manufacturing and Production, Sales and Marketing FDA, Nabriva, US, Xenleta, pharma, pneumonia
The FDA has awarded approval in the US to Nebriva Therapeutics’ Xenleta (lefamulin) for the treatment of adult patients with …
Drop in prescriptions for antibiotic leads to fewer cases of superbug in Wales
August 20, 2019Manufacturing and Production AMR, Antibiotics, C difficile, C. difficile, pharma, superbug
Cuts to the number of prescriptions for antibiotics have led to a drop in the number of cases of the …
Finding the needle in the haystack of rare disease
August 19, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Genomenon, Rare Genomics Institute, pharma, rare disease
Through the use of Genomenon’s AI-driven Mastermind Genomic Search Engine, the Rare Genomics Institute succeeded where a leading genetics laboratory …
Celgene’s Inrebic becomes second FDA-approved therapy for rare bone marrow disorder
August 19, 2019Sales and Marketing Cancer, Cerlgene, FDA, Inrebic, pharma, rare disease
Celgene is celebrating the approval in the US of its Janus kinase (JAK) 2 inhibitor Inrebic (fedratinib) in the treatment …
British and American healthcare professionals predict further delays to Brexit as Europeans expect no-deal
August 19, 2019Sales and Marketing EU, UK, US, brexit, brexit delay, healthcare, no-deal, pharma
The majority of healthcare professionals in Europe, Britain and America think Brexit will happen. However they do not believe that …
AbbVie scoops up FDA approval for Rinvoq in moderately to severely active rheumatoid arthritis
August 19, 2019Sales and Marketing AbbVie, FDA, Rinvoq, pharma, rheumatoid arthritis
The FDA has awarded marketing authorisation to AbbVie’s Rinvoq (upadacitinib) for the treatment of moderately to severely active rheumatoid arthritis, …
UK Government calls on social media companies to fight misinformation surrounding vaccines
August 19, 2019Sales and Marketing MMR, anti-vaxxers, measles, pharma, vaccination, vaccines
Boris Johnson has called on social media companies to come together to discuss ways in which they can promote accurate …
Novartis exec sold off shares before Zolgensma data scandal was revealed
August 19, 2019Sales and Marketing AveXis, Novartis, Shares, Zolgensma, pharma, stock market
An unnamed Novartis executive sold 925,400 Swiss francs (£778,665) worth of shares in the firm just weeks before the FDA …
Hundreds of patients turn to private cannabis clinics in UK
August 16, 2019Medical Communications Marijuana, NHS, UK, cannabis, medicinal cannabis, pharma
Hundreds of people have turned to private clinics, in an effort to gain access to medicinal cannabis in the UK, …
Pfizer recall two batches of migraine drug Relpax
August 16, 2019Medical Communications FDA, Pfizer, Relpax, migraine, pharma, recall
Pfizer has recalled two lots of its migraine drug Relpax over concerns about microbiological contamination. In a statement on the …
Regeneron invest $800 million into New York facilities
August 15, 2019Medical Communications East Greenbush, New York, Regeneron, pharma
Regeneron is investing $800 million into its New York production facilities. The firm is planning to build a four story …
Regeneron therapy halves LDL cholesterol levels in rare genetic condition
August 15, 2019Research and Development Regeneron, evinacumab, pharma, rare disease
Regeneron has reported a strong showing for its investigational angiopoietin-like 3 (ANGPTL3) antibody evinacumab in the treatment of the rare …
Lilly’s Taltz beats Janssen’s Tremfya at Phase 4 in plaque psoriasis
August 15, 2019Research and Development Eli Lilly, Taltz, Tremfya, pharma, psoriasis
Eli Lilly has unveiled new Phase 4 data supporting the efficacy and safety of Taltz (ixekizumab) when compared to Janssen’s …
Britain call on companies to bid for 24 hour Brexit medicines shipping service contract
August 15, 2019Business Services, Sales and Marketing UK, brexit, britain, medicines, pharma
The British Government is calling on logistics companies to bid for a £25 million contract to run express freight containers …
FDA approve new drug for treatment-resistant TB
August 15, 2019Research and Development FDA, TB, US, pharma, pretomanid, tuberculosis
The US FDA has approved BPaL, the TB Alliance’s treatment for drug-resistant tuberculosis (TB). The US regulator gave the go-ahead …
Latest content
Five Facts about cardiovascular disease
